Resource Library

DPP Audience & Provider Insights for the DPP Research and Marketing Plan: Phase 1 Research Findings

This report, by M&C Saatchi World Services, AVAC, and partners, highlights learnings from Human-Centered Design Research undertaken in 2022 to understand the values and motivations of potential users and influencers of the Dual Prevention Pill (DPP) in Kenya, South Africa, and Zimbabwe.

Demand Creation/Marketing

Private sector delivery opportunities for the DPP: Lessons from FP for the introduction of MPTs

With anticipated rollout of the DPP just two years away, planning for where to introduce the DPP in the private sector will be critical for ensuring access, but will hinge on where PrEP delivery is already permitted. This webinar shares new findings on private sector opportunities for the DPP in Kenya, South Africa and Zimbabwe.…

Service Delivery

Private sector delivery opportunities for the Dual Prevention Pill: Lessons from Family Planning for the introduction of Multi-purpose Prevention Technologies

Recording / Slides / Notes Please join AVAC and FP2030 for a webinar on the DPP, a daily pill that is currently being developed for simultaneous pregnancy and HIV prevention. This webinar will highlight new findings on private sector opportunities for the DPP in Kenya, South Africa and Zimbabwe. It will explore lessons and successes…

Service Delivery

Private Sector Delivery Opportunities for the Dual Prevention Pill

This scoping report provides an updated assessment of the private sector delivery options for the dual prevention pill (DPP) in the three countries that are targeted for the initial roll out of the DPP: Kenya, South Africa, and Zimbabwe. The report builds upon previous assessments and analysis that the DPP Consortium have carried out recently,…

Service Delivery

Blazing a trail for MPT counseling: Efforts to develop recommendations for the Dual Prevention Pill and reconcile inconsistent guidance for delivering PrEP and oral contraception

This poster from AIDS 2022 describes a process for future efforts to develop appropriate counseling guidance for Multipurpose Technologies, based on learnings from the Dual Prevention Pill and using missed pills as an illustrative example.

Community/Advocacy, Service Delivery

How Market Preparation for the Dual Prevention Pill is Reimagining Prevention Programs for a Future with MPTs

This slide deck presentation from AIDS 2022 describes how prevention programs can prepare for multipurpose prevention technology (MPTs) such as the Dual Prevention Pill, which combines protection against pregnancy and HIV, and offers marketing insights. The session also presents recommendations for provider counseling on a combined product. Watch the full session from AIDS 2022 here.

Community/Advocacy, Service Delivery

Dual Prevention Pill Desk Review Insights

This desk review by M&C Saatchi collates existing data and insights related to uptake and adherence to HIV prevention, contraceptive, and multi-purpose technology pill products; confirms and identifies gaps in the existing knowledge base; and prompts discussions around key learning questions that need to be addressed to develop a robust and effective marketing and demand…

Demand Creation/Marketing

Review of Effective Marketing and Demand Creation Strategies in HIV Prevention and Family Planning that May Inform Demand-Side Thinking for the Dual Prevention Pill

This scoping review aims to document effective and sustainable demand creation strategies used in HIV prevention and Family Planning interventions, how they may be adapted for the Dual Prevention Pill (DPP), and explores what could be done differently for the DPP.

Demand Creation/Marketing

The Years Ahead in Biomedical HIV Prevention Research

This graphic shows the updated status of large-scale prevention trials through 2024.

Community/Advocacy

IAS 2021 Satellite Session: Bringing the Dual Prevention Pill to Market: Opportunities for HIV and Pregnancy Prevention and Implications for Future MPTs

This video-recorded session from IAS 2021 examines opportunities for bringing the Dual Prevention Pill to market as well as implications for future multipurpose prevention technologies.